Move from Access to Apex Segment of Aquis

AI SummaryClose X

ProBiotix Health PLC announced that it has met the eligibility criteria to join the Apex segment of the Aquis Stock Exchange Growth Market. Trading on the Apex segment for the company's ordinary shares will commence on Monday, November 10, 2025. The Apex segment is designed for larger, more established businesses and includes additional eligibility criteria to promote greater transparency and liquidity. The company believes this transition validates its maturity and commercial achievements.

Disclaimer*

UK 100

Latest directors dealings